Evidence map›Paper›PMID 38317790›Full record

ArticleFrontiers in cellular and infection microbiology2023

Invasive

Cristina Uruén, Jorge Gimeno, Marina Sanz, Lorenzo Fraile, Clara M Marín, Jesús Arenas

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
23.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Cristina UruénUnit of Microbiology and Immunology, Faculty of Veterinary, University of Zaragoza, Zaragoza, Spain.
Jorge GimenoUnit of Microbiology and Immunology, Faculty of Veterinary, University of Zaragoza, Zaragoza, Spain.
Marina SanzUnit of Microbiology and Immunology, Faculty of Veterinary, University of Zaragoza, Zaragoza, Spain.
Lorenzo FraileDepartment of Animal Science, ETSEA, University of Lleida-Agrotecno, Lleida, Spain.
Clara M MarínInstitute Agrofood of Aragón-IA2, University of Zaragoza-CITA, Zaragoza, Spain.
Jesús ArenasUnit of Microbiology and Immunology, Faculty of Veterinary, University of Zaragoza, Zaragoza, Spain.
Universidad de Zaragoza · ESCentro de Investigación y Tecnología Agroalimentaria de Aragón · ESUniversitat de Lleida · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: Antibiotic susceptibility testing was performed for 116 isolates of different genetic backgrounds and geographic origins against 18 antibiotics of 9 families. The association between AMR and genotypes and the origin of the isolates were statistically analyzed using Pearson´s chi-square test and the likelihood ratio. The antimicrobial resistant genes were identified by whole genome sequencing analysis and PCR screenings. Results: High AMR rates (>80%) were detected for tetracyclines, spectinomycin, lincosamides, and marbofloxacin, medium (20-40%) for sulphonamides/trimethoprim, tiamulin, penicillin G, and enrofloxacin, and low (< 20%) for florfenicol, and four additional β-lactams. The occurrence of multidrug resistance was observed in 90% of isolates. For certain antibiotics (penicillin G, enrofloxacin, marbofloxacin, tilmicosin, and erythromycin), AMR was significantly associated with particular sequence types (STs), geographic regions, age of pigs, and time course. Whole genome sequencing comparisons and PCR screenings identified 23 AMR genes, of which 19 were previously reported in Conclusions: Our work evidences that

Indexed as

Anti-Infective AgentsStreptococcal InfectionsStreptococcus suisAnimalsAnti-Bacterial AgentsDiterpenesDrug Resistance, BacterialEnrofloxacinHumansLincosamidesMicrobial Sensitivity TestsPenicillin GPhylogenySpainSpectinomycinSwineAnti-Bacterial AgentsAnti-Infective AgentsDiterpenesEnrofloxacinLincosamidesPenicillin GSpectinomycinTetracyclinestiamulinTrimethoprimantimicrobial resistance (AMR)antimicrobial resistant genesICEsIMEsmobile genetic elementsStreptococcus sp.Streptococcus suis

Identifiers

PMID38317790
PMCPMC10839070
OpenAlexW4391108697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.